CLINICAL_TRIALS
trial_result
· 2019-08-21
Clinical Trial Update: Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis. [Phase 1, Phase 2]
Summary
Clinical trial update on fecal microbiota transplantation for primary sclerosing cholangitis (phases 1 and 2) completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Brigham and Women's Hospital | Conditions: Sclerosing Cholangitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-08-21